Nomura Holdings, Inc. (NMR) P/E Ratio History
Historical price-to-earnings valuation from 2003 to 2026
Loading P/E history...
Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of March 2, 2026, Nomura Holdings, Inc. (NMR) trades at a price-to-earnings ratio of 12.7x, with a stock price of $9.00 and trailing twelve-month earnings per share of $122.54.
The current P/E is 12775% above its 5-year average of 0.1x. Over the past five years, NMR's P/E has ranged from a low of 0.1x to a high of 0.3x, placing the current valuation at the 100th percentile of its historical range.
Compared to the Financial Services sector median P/E of 13.8x, NMR is roughly in line with its sector peers. The sector includes 789 companies with P/E ratios ranging from 0.0x to 196.2x.
The PEG ratio of 1.16 (P/E divided by 110% EPS growth) suggests a fair valuation relative to its earnings growth. Peter Lynch popularized the rule that a PEG below 1.0 indicates an attractive entry point.
Relative to the broader market, NMR trades at a notable discount to the S&P 500 median P/E of 26.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our NMR DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
Peer Comparison
P/E metrics vs. Investment Banking and M&A Advisory peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
GSThe Goldman Sachs Group, Inc. | $267B | 21.2 | 1.51 | +77% |
MSMorgan Stanley | $265B | 20.9 | 2.35 | +53% |
EVREvercore Inc. | $27B | 34.0 | 5.99 | +43% |
NMRNomura Holdings, Inc. | $27B | 12.7 | 1.16Best | +110% |
JEFJefferies Financial Group Inc. | $9B | 15.7 | - | -5% |
PIPRPiper Sandler Companies | $5B | 28.9 | 4.92 | +106% |
LAZLazard Ltd | $5B | 18.9 | 9.97 | +398% |
MCMoelis & Company | $4B | 33.3 | - | +594%Best |
HLIHoulihan Lokey, Inc. | $3B | 28.1 | 1.79 | +42% |
MDBHMDB Capital Holdings, LLC Class A common | $16M | 1.2Lowest | - | +407% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
Historical P/E Data
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q2 | Mon Oct 27 2025 00:00:00 GM | $7.08 | $120.97 | 0.1x | -80% |
| FY2026 Q1 | Mon Jun 30 2025 00:00:00 GM | $6.58 | $122.74 | 0.1x | -82% |
| FY2025 Q4 | Mon Mar 31 2025 00:00:00 GM | $6.15 | $111.00 | 0.1x | -81% |
| FY2025 Q3 | $5.79 | $105.72 | 0.1x | -81% | |
| FY2025 Q2 | Mon Sep 30 2024 00:00:00 GM | $5.22 | $88.74 | 0.1x | -80% |
| FY2025 Q1 | Sun Jun 30 2024 00:00:00 GM | $5.78 | $67.69 | 0.1x | -71% |
| FY2024 Q4 | Sun Mar 31 2024 00:00:00 GM | $6.42 | $52.73 | 0.1x | -59% |
| FY2024 Q3 | Sun Dec 31 2023 00:00:00 GM | $4.51 | $37.01 | 0.1x | -59% |
| FY2024 Q2 | Sat Sep 30 2023 00:00:00 GM | $4.02 | $42.42 | 0.1x | -68% |
| FY2024 Q1 | Fri Jun 30 2023 00:00:00 GM | $3.83 | $36.63 | 0.1x | -65% |
| FY2023 Q4 | Fri Mar 31 2023 00:00:00 GM | $3.80 | $29.35 | 0.1x | -56% |
| FY2023 Q3 | Sat Dec 31 2022 00:00:00 GM | $3.75 | $36.94 | 0.1x | -66% |
Average P/E for displayed period: 0.3x
See NMR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NMR Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare NMR vs JPM
See how NMR stacks up against sector leader JPMorgan Chase & Co..
Start ComparisonFrequently Asked Questions
Is NMR stock overvalued or undervalued?
NMR trades at 12.7x P/E, above its 5-year average of 0.1x. The 100th percentile ranking indicates a premium to historical valuation.
How does NMR's valuation compare to peers?
Nomura Holdings, Inc. P/E of 12.7x compares to sector median of 13.8x. The discount suggests lower growth expectations or higher risk.
What is NMR's PEG ratio?
NMR PEG ratio is 1.16. Between 1-2 suggests valuation aligns with growth. Historical P/E data spans 2003-2026.